conjugate
07/10/2019
Dr. Andrew Lees, Scientific Director of Fina BioSolutions LLC, giving a seminar at IVI July 9, 2019, Seoul, South Korea -Dr. Andrew Lees, Scientific Director of Fina BioSolutions LLC, gave a seminar today at IVI headquarters about the road towards affordable conjugate vaccines. During […]
07/25/2019
July 25, 2019 – SEOUL, South Korea. The International Vaccine Institute (IVI) is pleased to announce that EuBiologics, IVI’s key partner in Korea, received a 900 million Korean won ($760,000) award from the RIGHT Fund for the development of a cholera conjugate […]
